NSEGeneral Updates2d ago · 28 Aug 2026, 10:15 am

General Updates

Jubilant Pharmova Limited · JUBLPHARMA

✦ AI SummaryRegulatory

Jubilant Pharmova Limited has informed the Exchange about receiving a Show Cause Notice from the Joint Commissioner, CGST Division, Roorkee, proposing demand of GST, Interest and penalty for the Financial Year 2020-21 to 2021-2022.

Analysis Scores

Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Jubilant Pharmova Limited has informed the Exchange about General Updates

Attachments (1)

📄

JUBLPHARMA_28082026101506_PharmovaStockExchangeDisclosure.pdf

pdf

Download →
View document text
August 28, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange plaza, Dalal Street, Bandra-Kurla Complex, Mumbai - 400001 Bandra (E), Mumbai - 400051 Scrip Code: 530019 Scrip Code: JUBLPHARMA Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Dear Sir/Madam, Pursuant to Regulation 30 of the Listing Regulations read with Schedule III and the SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, with respect to receipt of Show Cause Notice by Jubilant Generics Limited, wholly-owned subsidiary of the Company, issued by the Joint Commissioner, CGST Division, Roorkee proposing demand of GST, Interest and penalty for the Financial Year 2020-21 to 2021-2022. The information in the relevant format is enclosed as Annexure-A. The Company is in the process of taking necessary action to file a detailed reply before the Joint Commissioner, CGST Division, Roorkee in response to the Show Cause Notice. Date and time of occurrence of event is August 27, 2026, 12.35 PM (IST). The above-mentioned document will be simultaneously posted on the Company's website at www.jubilantpharmova.com. We request you to take the same on record. Thanking you, Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary Annexure – A Sr. Brief details of Name of the Court/ Expected financial Quantum of No litigation opposing party tribunal/agenc implications, if any, demand (In Rs. y where due to Crore) litigation is compensation, filed penalty etc. 1. Show Cause Notice The Joint Reply will be The Show Cause GST (Tax) – Rs. received on 27th August Commissioner, filed before the Notice is factually and 52.75 Cr. 2026 (at 12.35 PM) CGST Division, Joint legally incorrect, bad Interest – Not issued by the Joint Roorkee, Commissioner, in law and has been Quantified Commissioner, CGST Uttarakhand CGST Division, issued without Penalty – Rs. Division, Roorkee, Roorkee, verifying the facts and 52.75 Cr Uttarakhand proposing Uttarakhand examining the issue demand of inadmissible contesting the properly. Company refund of IGST along demand has strong case in its with Interest and equal favour. penalty. The dispute relates to alleged The Company will file availment of IGST refund a detailed reply on under Rule 96 and merits before the benefit of Advance Joint Commissioner, Authorisation scheme CGST Division, simultaneously, in Roorkee. Therefore, violation of Rule 96(10) the Company expects of CGST Rules, 2017 for no financial or the FY 2020-2021 and operational impact. 2021-2022.